FDA approves the first fully autonomous AI for portable diabetic retinopathy screening
AEYE Health's FDA-cleared AI, AEYE-DS, enables autonomous diabetic retinopathy screening using handheld cameras, revolutionizing eye care accessibility and outcomes.
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020(photo credit: ANDREW KELLY / REUTERS)Updated: